Business Context and Reporting Period
Nanoviricides, Inc. filed a Form 8-K on February 25, 2014, reporting a material modification to the rights of security holders. The company is incorporated in Nevada and maintains its principal executive offices in West Haven, Connecticut.
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The report focuses exclusively on a corporate action regarding warrant terms.
Material Changes
Effective February 25, 2014, the company amended the terms of warrants to purchase an aggregate of 2,979,078 shares of common stock. The primary change was extending the expiration date of all warrants from February 28, 2014, to June 30, 2014. No other terms, including the exercise price of $3.50 per share, were amended.
- Warrant Breakdown:
- 84,572 shares (issued June 15, 2006)
- 428,571 shares (issued October 2007)
- 466,486 shares (issued August 22, 2008)
- 561,628 shares (issued June 30, 2009)
- 1,437,821 shares (issued September 30, 2009)
Guidance, Outlook, and Risks
The filing does not provide management commentary, financial guidance, outlook, or specific risk factors beyond the disclosure of the warrant modification. There are no unusual items or contingencies reported in this document.
Investor Verification Checklist
- Confirm the new expiration date of June 30, 2014, for the 2,979,078 outstanding warrants.
- Verify that the exercise price remains fixed at $3.50 per share for all warrant tranches.
- Check subsequent filings for any further amendments to warrant terms or exercise activity prior to the new expiration date.